Publications by authors named "Pierre Chan"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

242,549

Total Likes

6,886

Extended Reach

426,636

Social Features

50
P
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.
Thomas Yau, Paul N Cheng, Pierre Chan, Li Chen, Jimmy Yuen

Invest New Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.
Thomas Yau, P N Cheng, Pierre Chan, William Chan, Li Chen

Invest New Drugs· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm.
Carlos K H Wong, Cindy L K Lam, Wai-Lun Law, Jensen T C Poon, Pierre Chan

J Eval Clin Pract· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective.
Carlos K H Wong, Cindy L K Lam, Jensen T C Poon, Sarah M McGhee, Wai-Lun Law, Pierre Chan

J Eval Clin Pract· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease.
Thomas Yau, Hilda Wong, Pierre Chan, T J Yao, R Pang

Invest New Drugs· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits.
Joanne Chiu, Yuen Fong Tang, Tzy-Jyun Yao, Ashley Wong, Hilda Wong, Pierre Chan, Albert C Chan

Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
Carlos K H Wong, Cindy L K Lam, Donna Rowen, Sarah M McGhee, Ka-Ping Ma, Pierre Chan

Value Health· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).
Hilda Wong, Yuen Fong Tang, Tzy-Jyun Yao, Joanne Chiu, Roland Leung, Pierre Chan, Albert C Chan

Oncologist· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Being active or flexible? Role of control coping on quality of life among patients with gastrointestinal cancer.
Cecilia Cheng, Nga-Yan Chan, Jasmine Hin-Man Chio, Pierre Chan, Annie On-On Chan

Psychooncology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colon cancer in a patient with underlying aplastic anemia: A clinical challenge.
Hilda Wong, Pierre Chan, Thomas Yau

World J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.
Thomas Yau, T J Yao, Pierre Chan, Hilda Wong, Roberta Pang

Oncologist· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics.
Thomas Yau, Pei-Jer Chen, Pierre Chan, C Martin Curtis, Philip S Murphy

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.
Victoria P Y Tan, Wai M Wong, Ting K Cheung, Kam C Lai, Ivan F N Hung, Pierre Chan

J Gastroenterol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine-induced cholangiopathy: a case report.
Wai-Kay Seto, Matthew Ng, Pierre Chan, Irene Oi-Lin Ng, Stephen Chi-Wai Cheung

Am J Gastroenterol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.
Thomas Yau, Pierre Chan, Roberta Pang, Kelvin Ng, S T Fan

Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population.
Man-Fung Yuen, Cheuk-Kwong Lee, Danny Ka-Ho Wong, James Fung, Ivan Hung, Pierre Chan

Gut· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Thomas Yau, Roberta Pang, Pierre Chan, Ronnie T Poon

Expert Opin Pharmacother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend of colorectal cancer in Hong Kong: 1983-2006.
Yuk Kei Yee, Qing Gu, Ivan Hung, Victoria P Y Tan, Pierre Chan

J Gastroenterol Hepatol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease.
Thomas Yau, Hilda Wong, Pierre Chan, Tracy Chan, Joyce Mak

Clin Colorectal Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoprophylaxis in colorectal cancer: current concepts and a practical algorithm for use.
Victoria P Y Tan, Pierre Chan, Ivan F N Hung, Roberta Pang, Benjamin C Y Wong

Expert Opin Investig Drugs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Fook-Hong Ng, Siu-Yin Wong, Kwok-Fai Lam, Wai-Ming Chu, Pierre Chan

Gastroenterology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Thomas Yau, Tzy Jyun Yao, Pierre Chan, Richard John Epstein, Kelvin K Ng

Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Ivan F N Hung, Pierre Chan, Sally Leung, Fion S Y Chan, Axel Hsu, Chi Kuen Chan

Helicobacter· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of colorectal cancer in Asia.
Yuk Kei Yee, Victoria P Y Tan, Pierre Chan, Ivan F N Hung, Roberta Pang

J Gastroenterol Hepatol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis